Donald C. Coggins Jr. is a founding member of the law firm known today as Harrison, White, Smith & Coggins, P.C.
Coggins assists clients in a wide range of areas, including personal injury, business litigation and professional licensing matters.
He is licensed to practice in state and federal courts within South Carolina, the Fourth Circuit U.S. Court of Appeals and U.S. Supreme Court.
Coggins served on the legal team that obtained a $327 million verdict for the state of South Carolina against the companies behind the Risperdal antipsychotic drug in a case alleging marketing violations of the South Carolina Unfair Trade Practices Act.
He also played a role in obtaining settlements of $45 million and $26 million with Eli Lilly and AstraZeneca, respectively, in cases that involved similar drugs and legal claims.
Coggins is a Spartanburg native who earned his B.A. degree in Economics from Clemson University in 1981 and his law degree from the University of South Carolina School of Law in 1984.
His memberships include the American Association for Justice and South Carolina Association for Justice as well as the Spartanburg County Bar Association.
He currently serves on the Board of Directors for the Spartanburg Interfaith Hospitality Network and as a member of the South Carolina Commission on Lawyer Conduct.